Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 7, Issue 5, Pages 434-442Publisher
SPRINGER
DOI: 10.1007/s11910-007-0067-6
Keywords
-
Categories
Funding
- NATIONAL INSTITUTE ON AGING [R01AG026251, P01AG017216, P50AG016574] Funding Source: NIH RePORTER
- NIA NIH HHS [R01 AG026251, P50 AG16574, P01 AG017216] Funding Source: Medline
Ask authors/readers for more resources
The clinical disorders associated with frontotemporal lobar degeneration (FTLD) are increasingly recognized as an important cause of early-onset dementia. Patients usually present with progressive changes in personality, behavior, or language, progressing to general cognitive impairment and ultimately death. In the past decade, improved clinical and histopathologic characterization uncovered extensive heterogeneity, and multiple clinical and pathologic FTLD subtypes were defined. Simultaneously, the discovery of four causal FTLD genes emphasized the genetic complexity associated with FTLD. More recently, the field of FTLD has gained increased attention as a result of two major findings. First, mutations in the progranulin gene (PGRN) were recognized as a major cause of FTLD with ubiquitin-positive and tau-negative inclusions (FTLD-U), and subsequently the TAR DNA-binding protein-43 (TDP-43) was identified as a key protein within the ubiquitinated inclusions in FTLD-U and amyotrophic lateral sclerosis (ALS). In this report, we outline the progress made in the study of the genetic etiologies and neuropathologic substrates in FTLD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available